SCHEMBL31455595

SCHEMBL31455595

CCOC(=O)c1cccc(S(=O)(=O)CC)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.52
CYP4A11 Q02928 1/20 0.52
CA2 P00918 2/20 0.52
TSHR P16473 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
LMNA P02545 2/20 0.51
MAPT P10636 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
CA1 P00915 1/20 0.50
CA7 P43166 1/20 0.50
CA14 Q9ULX7 1/20 0.50
ALDH1A1 P00352 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6331051 0.88 CA12 (0.51) CYP4F2CYP4A11CA2TSHRSMN1; SMN2
SCHEMBL20590864 0.88 CA12 (0.54) CYP4F2CYP4A11CA2TSHRSMN1; SMN2
SCHEMBL20267173 0.88 LMNA (0.58) TSHRLMNAALDH1A1NPSR1
SCHEMBL8115498 0.87 TSHR (0.55) CYP4F2CYP4A11CA2TSHRSMN1; SMN2
SCHEMBL8114167 0.87 CYP4F2 (0.52) CYP4F2CYP4A11CA2TSHRSMN1; SMN2
SCHEMBL29015042 0.86 MAPT (0.53) CYP4F2CYP4A11CA2TSHRSMN1; SMN2
SCHEMBL397968 0.86 CYP4F2 (0.51) CYP4F2CYP4A11CA2TSHRSMN1; SMN2
SCHEMBL132039 0.86 CA2 (0.64) CYP4F2CYP4A11CA2TSHRCA12
SCHEMBL28597107 0.86 CA2 (0.49) CYP4F2CYP4A11CA2TSHRSMN1; SMN2
SCHEMBL23224423 0.85 LOX (0.54) CYP4F2CYP4A11CA2TSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed